Medicare and Medical Technology — The Growing Demand for Relevant Outcomes
- 4 February 2010
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 362 (5) , 377-379
- https://doi.org/10.1056/nejmp0912062
Abstract
In deciding whether to pay for new medical technologies, the Centers for Medicare and Medicaid Services (CMS) is becoming more specific about its requirements for evidence of improved health outcomes in the Medicare population. In our view, this is a positive and overdue step, but one whose rationale and likely consequences must be better understood by the medical community, policymakers, and the public. Expansions of access to health insurance under the health care reform legislation pending in Congress — and resulting financial pressures — would almost certainly intensify the emphasis on more relevant and robust evidence.Keywords
This publication has 4 references indexed in Scilit:
- CMS's Landmark Decision on CT Colonography — Examining the Relevant DataNew England Journal of Medicine, 2009
- Pay Now, Benefits May Follow — The Case of Cardiac Computed Tomographic AngiographyNew England Journal of Medicine, 2008
- Medicare’s National Coverage Decisions For Technologies, 1999–2007Health Affairs, 2008
- The New Technology AssessmentNew England Journal of Medicine, 1990